Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Sees Significant Decrease in Short Interest

Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 179,400 shares, a decline of 30.1% from the October 31st total of 256,600 shares. Currently, 0.9% of the company's stock are short sold. Based on an average trading volume of 194,600 shares, the days-to-cover ratio is currently 0.9 days.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Virtu Financial LLC bought a new stake in shares of Monogram Orthopaedics during the first quarter valued at approximately $32,000. State Street Corp bought a new stake in shares of Monogram Orthopaedics during the third quarter valued at approximately $62,000. Barclays PLC bought a new stake in shares of Monogram Orthopaedics during the third quarter valued at approximately $29,000. Finally, Geode Capital Management LLC grew its position in Monogram Orthopaedics by 1,267.4% in the third quarter. Geode Capital Management LLC now owns 210,144 shares of the company's stock valued at $557,000 after acquiring an additional 194,776 shares during the period. 0.45% of the stock is currently owned by institutional investors and hedge funds.

Monogram Orthopaedics Stock Performance

Shares of Monogram Orthopaedics stock traded up $0.02 during trading on Friday, hitting $2.02. 18,849 shares of the stock traded hands, compared to its average volume of 144,697. The stock has a market cap of $69.31 million, a P/E ratio of -4.30 and a beta of 2.28. Monogram Orthopaedics has a twelve month low of $1.53 and a twelve month high of $4.90. The company has a fifty day moving average price of $2.30 and a two-hundred day moving average price of $2.38.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.